Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs

Fribourg, Miguel, Moreno, José L., Holloway, Terrell, Provasi, Davide, Baki, Lia, Mahajan, Rahul, Park, Gyu, Adney, Scott K. +14 more·2011·Cell

Cited by (313)

Items 101–200 of 313

  1. Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
    Imane Frouni, Adjia Hamadjida, Cynthia Kwan, Dominique Bédard, Vaidehi Nafade, Fleur Gaudette, Stephen G. Nuara, Jim C. Gourdon, Francis Beaudry, Philippe Huot · 2019 · Neuropharmacology
  2. Repressive Epigenetic Changes at the mGlu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice
    Mitsumasa Kurita, José L. Moreno, Terrell D. Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García‐Bea, James B. Hanks, Rachael L. Neve, Eric J. Nestler, Scott J. Russo et al. · 2013 · Molecular Pharmacology
  3. Membrane-Sensitive Conformational States of Helix 8 in the Metabotropic Glu2 Receptor, a Class C GPCR
    Agostino Bruno, Gabriele Costantino, Gianni De Fabritiis, Manuel Pastor, Jana Selent · 2012 · PLoS ONE
  4. Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules
    Akihiro Mouri, Taku Nagai, Daisuke Ibi, Kiyofumi Yamada · 2012 · Neurobiology of Disease
  5. An update of novel screening methods for GPCR in drug discovery
    Linjie Chen, Lili Jin, Naiming Zhou · 2012 · Expert Opinion on Drug Discovery
  6. Understanding GPCR dimerization
    Agata Faron‐Górecka, Marta Szlachta, Magdalena Kolasa, Joanna Solich, Andrzej Górecki, Maciej Kuśmider, Dariusz Żurawek, Marta Dziedzicka‐Wasylewska · 2018 · Methods in cell biology
  7. Portraying G Protein-Coupled Receptors with Fluorescent Ligands
    Francisco Ciruela, Kenneth A. Jacobson, Víctor Fernández‐Dueñas · 2014 · ACS Chemical Biology
  8. Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells
    Lia Baki, Miguel Fribourg, Jason Younkin, José Miguel Eltit, José L. Moreno, Gyu Park, Zhanna V. Vysotskaya, Adishesh K. Narahari, Stuart C. Sealfon, Javier González‐Maeso et al. · 2016 · Pflügers Archiv - European Journal of Physiology
  9. The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent
    Joanna Monika Wierońska, A. Sławińska, Katarzyna Stachowicz, Magdalena Łasoń, Piotr Gruca, Mariusz Papp, Andrzej Pilc · 2013 · Behavioural Brain Research
  10. GPCR interaction as a possible way for allosteric control between receptors
    Jean‐Philippe Pin, Julie Kniazeff, Laurent Prézeau, Jiang-Feng Liu, Philippe Rondard · 2019 · Molecular and Cellular Endocrinology
  11. Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
    David Moreno‐Delgado, Mar Puigdellívol, Estefanía Moreno, Mar Rodríguez-Ruiz, Joaquín A. Botta, Paola Gasperini, Anna Chiarlone, Lesley A. Howell, Marco Scarselli, Vicent Casadó et al. · 2020 · eLife
  12. GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders
    Ferdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, Rosamaria Orlando, Anna Rita Zuena, Peter Jeffrey Conn, Shalini Dogra, Max E. Joffe · 2023 · Neuropharmacology
  13. 5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling
    Samy Murat, Mathilde Bigot, Jonathan Chapron, Gabriele Maria König, Evi Kostenis, Giuseppe Battaglia, Ferdinando Nicoletti, Emmanuel Bourinet, Joël Bockaert, Philippe Marin et al. · 2018 · Molecular Psychiatry
  14. TAPS: A traveling-salesman based automated path searching method for functional conformational changes of biological macromolecules
    Lizhe Zhu, Fu Kit Sheong, Siqin Cao, Song Liu, Ilona Christy Unarta, Xuhui Huang · 2019 · The Journal of Chemical Physics
  15. PDZK1/NHERF3 Differentially Regulates Corticotropin-releasing Factor Receptor 1 and Serotonin 2A Receptor Signaling and Endocytosis
    Cornelia Walther, Fabiana A. Caetano, Henry A. Dunn, Stephen S. G. Ferguson · 2015 · Cellular Signalling
  16. Classification and signaling characteristics of 5-HT receptors: toward the concept of 5-HT receptosomes
    Philippe Marin, Carine Bécamel, Séverine Chaumont‐Dubel, Franck Vandermoere, Joël Bockaert, Sylvie Claeysen · 2020 · Handbook of behavioral neuroscience
  17. Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
    Lamia Sid‐Otmane, Adjia Hamadjida, Stephen G. Nuara, Dominique Bédard, Fleur Gaudette, Jim C. Gourdon, Véronique Michaud, Francis Beaudry, Michel Panisset, Philippe Huot · 2020 · European Journal of Pharmacology
  18. G Protein-Coupled Receptor Heterocomplexes in Neuropsychiatric Disorders
    Moreno, José L., Holloway, Terrell, González-Maeso, Javier · 2013 · Progress in Molecular Biology and Translational Science
  19. The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
    Somdatta Saha, Javier González‐Maeso · 2023 · Neuropharmacology
  20. Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review
    F. Matrisciano, I. Panaccione, D. Grayson, F. Nicoletti, A. Guidotti · 2016 · Current Neuropharmacology
  21. Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications
    Ilaria Dal Prà, Ubaldo Armato, Anna Chiarini · 2019 · Frontiers in Pharmacology
  22. Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice
    Hong‐Yi Chiu, Ming‐Huan Chan, Mei-Yi Lee, Shao‐Tsu Chen, Zih-Yi Zhan, Hwei‐Hsien Chen · 2014 · The International Journal of Neuropsychopharmacology
  23. Novel and atypical pathways for serotonin signaling
    Joël Bockaert, Carine Bécamel, Séverine Chaumont‐Dubel, Sylvie Claeysen, Franck Vandermoere, Philippe Marin · 2021 · Faculty Reviews
  24. Functional Cooperation of Metabotropic Adenosine and Glutamate Receptors Regulates Postsynaptic Plasticity in the Cerebellum
    Yuji Kamikubo, Takeshi Shimomura, Yosuke Fujita, Toshihide Tabata, Taku Kashiyama, Takashi Sakurai, Kenkichi Fukurotani, Masanobu Kano · 2013 · Journal of Neuroscience
  25. Preclinical models of antipsychotic drug action
    José L. Moreno, Javier González‐Maeso · 2013 · The International Journal of Neuropsychopharmacology
  26. Biophysical Detection of Diversity and Bias in GPCR Function
    Werner C. Jaeger, Stephen Paul Armstrong, Stephen John Hill, Kevin D. G. Pfleger · 2014 · Frontiers in Endocrinology
  27. Pharmacological evidence for transactivation within melatonin MT 2 and serotonin 5‐HT 2C receptor heteromers in mouse brain
    Romain Gerbier, Delphine Ndiaye‐Lobry, Pablo Blanco Martínez de Morentin, Erika Cecon, Lora K. Heisler, Philippe Delagrange, Florence Gbahou, Ralf Jockers · 2020 · The FASEB Journal
  28. 5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis
    Guendalina Olivero, Massimo Grilli, Matteo Vergassola, Tommaso Bonfiglio, Cristina Padolecchia, Beatrice Garrone, Francesco Paolo Di Giorgio, Serena Tongiani, Cesare Usai, Mario Marchi et al. · 2018 · Neuropharmacology
  29. Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors
    Jordana K. Thibado, Jean‐Yves Tano, Joon Lee, Leslie A. Salas-Estrada, Davide Provasi, Alexa Strauss, João Marcelo Lamim Ribeiro, Guoqing Xiang, Johannes Broichhagen, Marta Filizola et al. · 2021 · eLife
  30. Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice
    Salvador Sierra, Karan H. Muchhala, Donald K. Jessup, Katherine M. Contreras, Urjita H. Shah, David L. Stevens, Jennifer Jimenez, Xiomara K. Cuno Lavilla, Mario de la Fuente Revenga, Kumiko M. Lippold et al. · 2022 · Neuropharmacology
  31. D2-like dopamine and β-adrenergic receptors form a signaling complex that integrates Gs- and Gi-mediated regulation of adenylyl cyclase
    R. Victor Rebois, Karl Maki, Julie A. Meeks, Peter H. Fishman, Terence E. Hébert, John K. Northup · 2012 · Cellular Signalling
  32. PSD-95 regulates CRFR1 localization, trafficking and β-arrestin2 recruitment
    Henry A. Dunn, Harpreet S. Chahal, Fabiana A. Caetano, Kevin D. Holmes, George Y. Yuan, Ruchi Parikh, Bryan Heit, Stephen S. G. Ferguson · 2016 · Cellular Signalling
  33. Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control
    Mari Kondo, Katsunori Tajinda, Carlo Colantuoni, Hideki Hiyama, Saurav Seshadri, B Huang, Sovitj Pou, Keiko Furukori, Caroline Hookway, Hanna Jaaro-Peled et al. · 2013 · Translational Psychiatry
  34. G‐Protein‐Coupled Receptor Heteromers as Key Players in the Molecular Architecture of the Central Nervous System
    Marc Brugarolas, Gemma Navarro, Eva Martínez‐Pinilla, Edgar Angelats, Vicent Casadó, José Luis Lanciego, Rafael Franco · 2014 · CNS Neuroscience & Therapeutics
  35. Deep learning path-like collective variable for enhanced sampling molecular dynamics.
    Thorben Fröhlking, L. Bonati, Valerio Rizzi, F. Gervasio · 2024 · Journal of Chemical Physics
  36. Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
    Irene Fasciani, Francesco Petragnano, Gabriella Aloisi, Francesco Marampon, Marco Carli, Marco Scarselli, Roberto Maggio, Mario Rossi · 2020 · Pharmaceuticals
  37. Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer
    Daniel Pulido, Verònica Casadó-Anguera, Marc Gómez‐Autet, Natàlia Llopart, Estefanía Moreno, Nil Casajuana-Martín, Sergi Ferré, Leonardo Pardo, Vicent Casadó, Míriam Royo · 2022 · Journal of Medicinal Chemistry
  38. Synthesis toward Bivalent Ligands for the Dopamine D2 and Metabotropic Glutamate 5 Receptors
    Mingcheng Qian, Elise Wouters, James A. R. Dalton, Martijn Risseeuw, René A. J. Crans, Christophe Pol Stove, Jesús Giraldo, Kathleen Van Craenenbroeck, Serge Van Calenbergh · 2018 · Journal of Medicinal Chemistry
  39. Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats
    Jonathan Reinwald, Christian Nikolaus Schmitz, Ivan Skorodumov, Martin Kuchař, Wolfgang Weber‐Fahr, Rainer Spanagel, Marcus W. Meinhardt · 2023 · Translational Psychiatry
  40. G Protein-Coupled Receptor Signaling to Kir Channels in Xenopus Oocytes
    Candice N. Hatcher-Solis, Miguel Fribourg, Katerina Spyridaki, Jason Younkin, Amr Ellaithy, Guoqing Xiang, George Liapakis, Javier González‐Maeso, Hailin Zhang, Meng Cui et al. · 2014 · Current Pharmaceutical Biotechnology
  41. Adrenergic control of lymphocyte trafficking and adaptive immune responses
    Akiko Nakai, Kazuhiro Suzuki · 2018 · Neurochemistry International
  42. T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival
    Divya Anna Verghese, Markus Demir, Nicholas H. Chun, Miguel Fribourg, Paolo Cravedi, Inés Llaudó, Trent M. Woodruff, Pragya Dhruv Yadav, Sérgio A. Lira, M. Edward Medof et al. · 2018 · The Journal of Immunology
  43. Role of SAP97 in the Regulation of 5-HT2AR Endocytosis and Signaling
    Henry A. Dunn, Cornelia Walther, George Y. Yuan, Fabiana A. Caetano, Christina M. Godin, Stephen S. G. Ferguson · 2014 · Molecular Pharmacology
  44. Neurobehavioral and neurodevelopmental profiles of a heuristic genetic model of differential schizophrenia- and addiction-relevant features: The RHA vs. RLA rats
    Alberto Fernández‐Teruel, Ignasi Oliveras, Toñi Cañete, Cristóbal Río-Álamos, Carles Tapias-Espinosa, Daniel Sampedro-Viana, Ana Sánchez-González, Francesco Sanna, Rafael Torrúbia, Javier González‐Maeso et al. · 2021 · Neuroscience & Biobehavioral Reviews
  45. Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
    Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, Benedetta Mazza, Annarita Barone, Licia Vellucci · 2023 · International Journal of Molecular Sciences
  46. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT2A receptor
    Antara A. Banerjee, Vidita A. Vaidya · 2020 · Biochemical and Biophysical Research Communications
  47. Asymmetric activation of dimeric GABAB and metabotropic glutamate receptors
    Lei Liu, Lin Li, Cangsong Shen, Philippe Rondard, Jean‐Philippe Pin, Chanjuan Xu, Jianfeng Liu · 2023 · American Journal of Physiology-Cell Physiology
  48. Computational Approaches for Modeling GPCR Dimerization
    Xuan-Yu Meng, Mihaly Mezei, Meng Cui · 2014 · Current Pharmaceutical Biotechnology
  49. L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor
    Daiki Masukawa, Motokazu Koga, Anna Sezaki, Yuka Nakao, Yuji Kamikubo, Tatsuo Hashimoto, Yuki Okuyama-Oki, Aderemi Caleb Aladeokin, Fumio Nakamura, Utako Yokoyama et al. · 2017 · JCI Insight
  50. Site-Specific Incorporation of Genetically Encoded Photo-Crosslinkers Locates the Heteromeric Interface of a GPCR Complex in Living Cells
    Urjita H. Shah, Rudy Toneatti, Supriya A. Gaitonde, Jong Moon Shin, Javier González‐Maeso · 2020 · Cell chemical biology
  51. HDAC2 as a new target to improve schizophrenia treatment
    Mitsumasa Kurita, Terrell D. Holloway, Javier González‐Maeso · 2012 · Expert Review of Neurotherapeutics
  52. Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology
    Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, Alex T. Zhao, Katrin H. Preller, Robin Lester Carhart-Harris, Morten L. Kringelbach · 2024 · Translational Psychiatry
  53. Novel approaches to drug design for the treatment of schizophrenia
    Antoine Taly · 2013 · Expert Opinion on Drug Discovery
  54. Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    Cynthia Kwan, Imane Frouni, Stephen G. Nuara, Sébastien Belliveau, Woojin Kang, Adjia Hamadjida, Dominique Bédard, Francis Beaudry, Michel Panisset, Jim C. Gourdon et al. · 2021 · Neuropharmacology
  55. Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
    Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt · 2023 · Cells
  56. Serotonin-2A homodimers are needed for signalling via both phospholipase A 2 and phospholipase C in transfected CHO cells
    Alba Iglesias, Marta Cimadevila, Marı́a Isabel Cadavid, Marı́a Isabel Loza, Jose Manuel Brea · 2017 · European Journal of Pharmacology
  57. Drug Design Strategies for GPCR Allosteric Modulators
    Peter Jeffrey Conn, Scott D. Kuduk, Darı́o Doller · 2012 · Annual reports in medicinal chemistry
  58. Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801
    Peter U. Hámor, Jana Šírová, Tomáš Páleníček, Magdalena Zaniewska, Vĕra Bubeníková‐Valešová, Marek Schwendt · 2018 · Pharmacology Biochemistry and Behavior
  59. Beyond Standard Molecular Dynamics: Investigating the Molecular Mechanisms of G Protein-Coupled Receptors with Enhanced Molecular Dynamics Methods
    Jennifer M. Johnston, Marta Filizola · 2013 · Advances in experimental medicine and biology
  60. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen
    Adam L. Halberstadt, Jochem V. F. van der Zee, Muhammad Chatha, Mark A. Geyer, Susan B. Powell · 2018 · Psychopharmacology
  61. Class A and C GPCR Dimers in Neurodegenerative Diseases
    Irina Sousa Moreira, Ana B. Caniceiro, Beatriz Bueschbell, Anke C. Schiedel · 2022 · Current Neuropharmacology
  62. Psychedelics action and schizophrenia
    M. Maćkowiak · 2023 · Pharmacological Reports
  63. Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensor
    Maarten L. J. Doornbos, Ilse Van der Linden, Liesbeth Vereyken, Gary Tresadern, Adriaan P. IJzerman, Hilde Lavreysen, Laura H. Heitman · 2018 · Biochemical Pharmacology
  64. Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs
    Donard S. Dwyer, Eric J. Aamodt, Bruce M. Cohen, Edgar A. Buttner · 2014 · Frontiers in Pharmacology
  65. Adaptive mechanisms following antidepressant drugs: Focus on serotonin 5-HT2A receptors
    Dawid Gawliński, Irena Smaga, Magdalena Zaniewska, Kinga Gawlińska, Agata Faron‐Górecka, Małgorzata Filip · 2019 · Pharmacological Reports
  66. Presynaptic 5-HT2A-mGlu2/3 Receptor–Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis
    Alice Taddeucci, Guendalina Olivero, Alessandra Roggeri, Claudio Milanese, Francesco Paolo Di Giorgio, Massimo Grilli, Mario Marchi, Beatrice Garrone, Anna Pittaluga · 2022 · Cells
  67. Novel Screening Assay for the Selective Detection of G-Protein-Coupled Receptor Heteromer Signaling
    Richard M. van Rijn, Jessica H. Harvey, Daniela I. Brissett, Julia N. DeFriel, Jennifer L. Whistler · 2012 · Journal of Pharmacology and Experimental Therapeutics
  68. Family a GPCR heteromers in animal models
    Javier González‐Maeso · 2014 · Frontiers in Pharmacology
  69. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats
    Ignasi Oliveras, Ana Sánchez-González, Daniel Sampedro-Viana, Maria Antonietta Piludu, Cristóbal Río-Álamos, Osvaldo Giorgi, Maria Giuseppa Corda, Susana Aznar, Javier González‐Maeso, Cristina Gerbolés et al. · 2017 · Psychopharmacology
  70. Paroxetine and Low-dose Risperidone Induce Serotonin 5-HT1A and Dopamine D2 Receptor Heteromerization in the Mouse Prefrontal Cortex
    Magdalena Kolasa, Joanna Solich, Agata Faron‐Górecka, Dariusz Żurawek, Paulina Pabian, Sylwia Łukasiewicz, Maciej Kuśmider, Kinga Szafran‐Pilch, Marta Szlachta, Marta Dziedzicka‐Wasylewska · 2018 · Neuroscience
  71. Role of mGlu2 in the 5-HT2A receptor-dependent antipsychotic activity of clozapine in mice
    Kelsey S. Hideshima, Ashkhan Hojati, Justin M. Saunders, Doan M. On, Mario de la Fuente Revenga, Jong Moon Shin, Ana Sánchez-González, Cassandra M. Dunn, Alexander B. Pais, A. Christian Pais et al. · 2018 · Psychopharmacology
  72. GPCR signaling: role in mediating the effects of early adversity in psychiatric disorders
    Praachi Tiwari, Sashaina E. Fanibunda, Darshana Kapri, Shweta Vasaya, Sthitapranjya Pati, Vidita A. Vaidya · 2021 · FEBS Journal
  73. AiGPro: a multi-tasks model for profiling of GPCRs for agonist and antagonist
    Rahul Brahma, Sunghyun Moon, Jae-Min Shin, Kwang‐Hwi Cho · 2025 · Journal of Cheminformatics
  74. Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
    Imane Frouni, Cynthia Kwan, Stephen G. Nuara, Sébastien Belliveau, Woojin Kang, Adjia Hamadjida, Dominique Bédard, Jim C. Gourdon, Philippe Huot · 2021 · Journal of Neural Transmission
  75. Role of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects
    Daisuke Ibi · 2022 · Pharmacology Biochemistry and Behavior
  76. Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations
    Ajay Jajodia, Harpreet Kaur, Kalpana Kumari, Neha Kanojia, Meenal Gupta, Ruchi Baghel, Mamta Sood, Sanjeev Jain, Rakesh Kumar Chadda, Ritushree Kukreti · 2015 · Molecular Genetics & Genomic Medicine
  77. Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia
    Laura Nisenbaum, AnnCatherine M. Downing, Fangyi Zhao, Brian A. Millen, Leanne M. Munsie, Bruce J. Kinon, David H. Adams, Juan Gomez, Michelle A. Penny · 2016 · Journal of Personalized Medicine
  78. G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism
    Jon DelaCuesta-Barrutia, Olga Peñagarikano, Amaia Maite Erdozain · 2020 · Frontiers in Cellular Neuroscience
  79. Continuing challenges in targeting oligomeric GPCR-based drugs
    Joaquín A. Botta, Julia Appelhans, Peter James McCormick · 2020 · Progress in molecular biology and translational science
  80. Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis
    Nathan Bénac, G. Ezequiel Saraceno, Corey Butler, Nahoko Kuga, Yuya Nishimura, Taiki Yokoi, Ping Su, Takuya Sasaki, Mar Petit‐Pedrol, Rémi Galland et al. · 2024 · Nature Communications
  81. N-acetylcysteine modulates hallucinogenic 5-HT2A receptor agonist-mediated responses: Behavioral, molecular, and electrophysiological studies
    Mei-Yi Lee, Chun‐Cheng Chiang, Hong‐Yi Chiu, Ming‐Huan Chan, Hwei‐Hsien Chen · 2014 · Neuropharmacology
  82. MT2 melatonin receptors expressed in the olfactory bulb modulate depressive-like behavior and olfaction in the 6-OHDA model of Parkinson's disease
    Ana Carolina D. Noseda, Laís Soares Rodrigues, Adriano Targa, Jéssica L. Ilkiw, Juliane Fagotti, Patricia D. dos Santos, Erika Cecon, Regina Pekelmann Markus, Michele Solimena, Ralf Jockers et al. · 2020 · European Journal of Pharmacology
  83. Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors
    Hugo Rubén Arias, Laura Micheli, Anders A. Jensen, Sonya Galant, Franck Vandermoere, Daniel Venturi, Dina Manetti, María Novella Romanelli, Carla Ghelardini, Philippe Marin et al. · 2025 · Biomedicine & Pharmacotherapy
  84. Prostaglandin E Receptor EP1 Forms a Complex with Dopamine D1 Receptor and Directs D1-Induced cAMP Production to Adenylyl Cyclase 7 through Mobilizing G Subunits in Human Embryonic Kidney 293T Cells
    Aliza T. Ehrlich, Tomoyuki Furuyashiki, Shiho Kitaoka, Akira Kakizuka, Shuh Narumiya · 2013 · Molecular Pharmacology
  85. 5-HT2A Receptors and BDNF Regulation: Implications for Psychopathology
    Minal Jaggar, Vidita A. Vaidya · 2018 · Springer eBooks
  86. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT 2A /mGlu 2 Receptor Complex
    Christian B. M. Poulie, Na Liu, Anders A. Jensen, Lennart Bunch · 2020 · Journal of Medicinal Chemistry
  87. Cortical influences of serotonin and glutamate on layer V pyramidal neurons
    Gerard J. Marek, Darryle D. Schoepp · 2021 · Progress in brain research
  88. A stochastic approach to serotonergic fibers in mental disorders
    Skirmantas Janušonis, Nils Detering · 2018 · Biochimie
  89. The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
    Licia Vellucci, Mariateresa Ciccarelli, Elisabetta Filomena Buonaguro, Michele Fornaro, Giordano D’Urso, Giuseppe De Simone, Felice Iasevoli, Annarita Barone, Andrea de Bartolomeis · 2023 · Biomolecules
  90. Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine
    Danielle L. Taylor, Arun Kumar Tiwari, Jeffrey Alan Lieberman, Steven G. Potkin, Herbert Y. Meltzer, Jo Knight, Gary J. Remington, Daniel J. Müller, James L. Kennedy · 2016 · Complex Psychiatry
  91. Identification of amino acids that are selectively involved in Gi/o activation by rat melanin-concentrating hormone receptor 1
    Akie Hamamoto, Yuki Kobayashi, Yumiko Saito · 2015 · Cellular Signalling
  92. Allosteric binding cooperativity in a kinetic context
    Óscar Díaz, Victor S. Martı́n, Pedro Renault, David Romero, Antoni Guillamon, Jesús Giraldo · 2022 · Drug Discovery Today
  93. Natural Product-Based Drug Designing for Treatment of Human Parasitic Diseases
    Shaban Ahmad, Avtar Kishan, Pragya Chitkara, Saeed A. Asiri, Murugesh Eswaran, Sahil Mehta, Mansaf Alam · 2023 · Springer eBooks
  94. His452Tyr polymorphism in the human 5-HT2A receptor affects clozapine-induced signaling networks revealed by quantitative phosphoproteomics
    Sandra M. Martín‐Guerrero, Paula Alonso-Batan, Alba Iglesias, Marta Cimadevila, Jose Manuel Brea, Marı́a Isabel Loza, Pedro Casado, David Martín‐Oliva, Pedro R. Cutillas, Javier González‐Maeso et al. · 2021 · Biochemical Pharmacology
  95. Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans
    Limin Hao, Oshrit Ben‐David, Suzann M. Babb, Anthony H. Futerman, Bruce M. Cohen, Edgar A Buttner · 2016 · Neuropsychopharmacology
  96. LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration
    Jong Min Hong, Jin Woo Lee, Dong‐Seung Seen, Jae-Yeon Jeong, Won‐Ki Huh · 2023 · Cell Communication and Signaling
  97. Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders
    Maleesha Ubhayarathna, Christopher J. Langmead, Natalie A. Diepenhorst, Gregory D. Stewart · 2023 · British Journal of Pharmacology
  98. Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset
    Stephen G. Nuara, Adjia Hamadjida, Cynthia Kwan, Dominique Bédard, Imane Frouni, Jim C. Gourdon, Philippe Huot · 2020 · Journal of Neural Transmission
  99. Correction: Membrane-Sensitive Conformational States of Helix 8 in the Metabotropic Glu2 Receptor, a Class C GPCR
    Agostino Bruno, Gabriele Costantino, Gianni De Fabritiis, Manuel Pastor, Jana Selent · 2012 · PLoS ONE
  100. TrkB receptor interacts with mGlu 2 receptor and mediates antipsychotic-like effects of mGlu 2 receptor activation in the mouse
    Clémentine Eva Philibert, Candice Disdier, Pierre‐André Lafon, Alexandre Bouyssou, Mathieu Oosterlaken, Sonya Galant, Anne Pizzoccaro, Pola Tuduri, Jeanne Ster, Jianfeng Liu et al. · 2024 · Science Advances